Nippon Shinyaku Co Ltd (4516):企業の財務・戦略的SWOT分析

◆英語タイトル:Nippon Shinyaku Co Ltd (4516) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH31788FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Nippon Shinyaku Co Ltd (4516) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Nippon Shinyaku Co Ltd (Nippon Shinyaku) develops, manufactures and sells ethical pharmaceuticals and functional foods. The company offers a wide range of products including drugs for pain, inflammation, and allergies; urological diseases; hematologic malignancies; gastrointestinal disorders; cardiovascular and metabolic diseases among others. Nippon Shinyaku also provides functional food ingredients including health food ingredients, preservatives, spices and condiments, and protein preparations. Its functional food products find application in meat processing, fish processing, dairy product, prepared food, confectionery and bakery, and beverage, among others. The company operates business through a network of offices and research laboratories in Japan, China, the UK and the US. Nippon Shinyaku is headquartered in Minami-ku, Kyoto, Japan.

Nippon Shinyaku Co Ltd Key Recent Developments

Nov 13,2020: The “Moshikashite NMD” project is launched. Special dance and check tools are developed collaboratively to help discover neuromuscular disorders earlier
Jul 01,2020: Nippon Shinyaku : Investment in the newly established Biotech funds
Mar 24,2020: Nippon Shinyaku announces final completion of API manufacturing building
Jan 20,2020: Nippon Shinyaku signed the United Nations Global Compact (UNGC)

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Nippon Shinyaku Co Ltd – Key Facts
Nippon Shinyaku Co Ltd – Key Employees
Nippon Shinyaku Co Ltd – Key Operational Employees
Nippon Shinyaku Co Ltd – Major Products and Services
Nippon Shinyaku Co Ltd – History
Nippon Shinyaku Co Ltd – Company Statement
Nippon Shinyaku Co Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Nippon Shinyaku Co Ltd – Business Description
Business Segment: Functional Food
Overview
Performance
Business Segment: Pharmaceuticals
Overview
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Other
Performance
R&D Overview
Nippon Shinyaku Co Ltd – Corporate Strategy
Nippon Shinyaku Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Nippon Shinyaku Co Ltd – Strengths
Nippon Shinyaku Co Ltd – Weaknesses
Nippon Shinyaku Co Ltd – Opportunities
Nippon Shinyaku Co Ltd – Threats
Nippon Shinyaku Co Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Nippon Shinyaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Nippon Shinyaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Nippon Shinyaku Co Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 13, 2020: The “Moshikashite NMD” project is launched. Special dance and check tools are developed collaboratively to help discover neuromuscular disorders earlier
Jul 01, 2020: Nippon Shinyaku : Investment in the newly established Biotech funds
Mar 24, 2020: Nippon Shinyaku announces final completion of API manufacturing building
Jan 20, 2020: Nippon Shinyaku signed the United Nations Global Compact (UNGC)
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Nippon Shinyaku Co Ltd, Key Facts
Nippon Shinyaku Co Ltd, Key Employees
Nippon Shinyaku Co Ltd, Key Operational Employees
Nippon Shinyaku Co Ltd, Major Products and Services
Nippon Shinyaku Co Ltd, History
Nippon Shinyaku Co Ltd, Other Locations
Nippon Shinyaku Co Ltd, Subsidiaries
Nippon Shinyaku Co Ltd, Key Competitors
Nippon Shinyaku Co Ltd, Ratios based on current share price
Nippon Shinyaku Co Ltd, Annual Ratios
Nippon Shinyaku Co Ltd, Annual Ratios (Cont...1)
Nippon Shinyaku Co Ltd, Annual Ratios (Cont...2)
Nippon Shinyaku Co Ltd, Interim Ratios
Nippon Shinyaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Nippon Shinyaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Nippon Shinyaku Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Nippon Shinyaku Co Ltd (4516):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vaccinex Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Vaccinex Inc (Vaccinex) is a clinical-stage biotechnology company that discovers and develops targeted biotherapeutics to treat neurodegenerative diseases, cancer and autoimmune disorders. The company’s lead platform technologies include antibody platform and ActivMAb, SEMA4D, and antibody d …
  • Aboitiz Power Corporation (AP):電力:M&Aディール及び事業提携情報
    Summary Aboitiz Power Corporation (Aboitiz Power) a subsidiary of Aboitiz Equity Ventures Inc is a holding company that operates privately-owned generation companies and distribution utilities. Its power generation portfolio sources include hydropower, geothermal, coal, and oil. The company sells it …
  • China Haisheng Juice Holdings Co Ltd
    China Haisheng Juice Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Haisheng Juice Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Point Resources AS:石油・ガス:M&Aディール及び事業提携情報
    Summary Point Resources AS (Point Resources) ,is engaged in developing, exploring and production of petroleum products. It explores and produces crude oil, gas and natural gas liquids (NGLs) through Ringhorne, Balder and Jotun fields. Point Resources also offers seismic surveys and drilling services …
  • Nippon Chemiphar Co Ltd (4539):企業の財務・戦略的SWOT分析
    Summary Nippon Chemiphar Co Ltd (Nippon Chemiphar) is a provider of pharmaceutical drugs and health-related services. The company manufactures, supplies, imports and exports ethical pharmaceuticals and diagnostic agents. It offers diagnostic products, such as IgE NC, a diagnostic kit that provides r …
  • The Straits Trading Co Ltd:企業の戦略・SWOT・財務情報
    The Straits Trading Co Ltd - Strategy, SWOT and Corporate Finance Report Summary The Straits Trading Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Unity Biotechnology Inc (UBX):製薬・医療:M&Aディール及び事業提携情報
    Summary Unity Biotechnology Inc (Unity Biotechnology), formerly Forge Inc is a biotechnology company that researches, develops and commercializes therapeutics for the treatment of age-related diseases. The company focuses on the development of senolytic medicines to eliminate senescent cells. The co …
  • Sirius International Insurance Corp:企業の戦略・SWOT・財務分析
    Sirius International Insurance Corp - Strategy, SWOT and Corporate Finance Report Summary Sirius International Insurance Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • GE Power-エネルギー分野:企業M&A・提携分析
    Summary GE Power (GEP), formerly GE Power & Water, a business division of the General Electric Company, is a provider of power generation and water processing products and related services. Its product portfolio includes aeroderivative and heavy-duty gas turbine systems, generators, boilers, steam t …
  • XenoPort Inc-製薬・医療分野:企業M&A・提携分析
    Summary XenoPort Inc (XenoPort) is a bio-pharmaceutical company which develops and commercializes internally discovered product candidates for the treatment of neurological disorders. It develops Transported Prodrugs through the modification of chemical structure of existing drugs in the market. The …
  • Select Energy Services Inc (WTTR):企業の財務・戦略的SWOT分析
    Select Energy Services Inc (WTTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Hokuriku Electric Power Co (9505):企業の財務・戦略的SWOT分析
    Hokuriku Electric Power Co (9505) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Arcadis NV:戦略・SWOT・企業財務分析
    Arcadis NV - Strategy, SWOT and Corporate Finance Report Summary Arcadis NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • ZyGEM NZ Ltd:医療機器:M&Aディール及び事業提携情報
    Summary ZyGEM NZ Ltd (ZyGEM), a subsidiary of MicroGEM International PLC is a drug development company that develops and technologies for life science, agricultural and horticultural industries. The company produces DNA extraction products, and enzymes used in diagnostics, molecular biology and indu …
  • Chori Co Ltd (8014):企業の財務・戦略的SWOT分析
    Chori Co Ltd (8014) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Dairyland Power Cooperative:発電所・企業SWOT分析
    Dairyland Power Cooperative - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key e …
  • Technogenetics srl-医療機器分野:企業M&A・提携分析
    Summary Technogenetics srl (Technogenetics), a subsidiary of Shanghai Kehua Bio-engineering Co Ltd, is a biotechnology company that offers reagents in the field of biotechnology and pharmacology. The company provides immunodiagnostics products in the areas of infectious disease, and autoimmunity. It …
  • Valmet Corp (VALMT):企業の財務・戦略的SWOT分析
    Valmet Corp (VALMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • South Egypt Drug Industries Co:企業の戦略的SWOT分析
    South Egypt Drug Industries Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Unigroup Inc:企業の戦略・SWOT・財務分析
    Unigroup Inc - Strategy, SWOT and Corporate Finance Report Summary Unigroup Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆